Search company, investor...

Founded Year

2017

Stage

IPO | IPO

Total Raised

$200K

Date of IPO

1/26/2023

About Bullfrog AI

Bullfrog AI (NASDAQ: BFRG) is a digital biopharma company that helps biopharmaceutical companies develop clinical development programs. The company uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its product includes bfLEAP. Bullfrog AI was founded in 2017 and is based in Gaithersburg, Maryland.

Headquarters Location

325 Ellington Boulevard Suite 317

Gaithersburg, Maryland, 20878,

United States

240-658-6710

Loading...

Loading...

Research containing Bullfrog AI

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Bullfrog AI in 1 CB Insights research brief, most recently on Aug 1, 2023.

Expert Collections containing Bullfrog AI

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Bullfrog AI is included in 2 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

10,958 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

D

Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Latest Bullfrog AI News

BullFrog AI to Present at Benzinga All Access Event on October 20

Oct 18, 2023

Safe Harbor Statement This press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. Investor Contact:

Bullfrog AI Frequently Asked Questions (FAQ)

  • When was Bullfrog AI founded?

    Bullfrog AI was founded in 2017.

  • Where is Bullfrog AI's headquarters?

    Bullfrog AI's headquarters is located at 325 Ellington Boulevard, Gaithersburg.

  • What is Bullfrog AI's latest funding round?

    Bullfrog AI's latest funding round is IPO.

  • How much did Bullfrog AI raise?

    Bullfrog AI raised a total of $200K.

  • Who are the investors of Bullfrog AI?

    Investors of Bullfrog AI include Maryland Technology Development Corporation and Johns Hopkins University.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.